NorthStar to Build New Production Line of Medical Radioisotopes
By MedImaging International staff writers Posted on 09 Jun 2016 |
Image: The University of Missouri Research Reactor (MIRR) (Photo courtesy of the University of Missouri).
NorthStar Medical Radioisotopes (Madison, WI, USA) will construct a new filling line that will quadruple the company’s capacity to dispense molybdenum-99 (Mo-99).
The new high-capacity medical radioisotope filling line will be installed at the University of Missouri Research Reactor (MURR; Columbia, MO, USA) by Von Gahlen International (Zevenaar, The Netherlands). The system will include a high-capacity DPharm unit to fill source vessels quickly, along with companion nuclear radiation containment chambers. The vessels will then be shipped to customers for use with the RadioGenix isotope separation system.
In addition to significantly increasing dispensing capacity at MURR, the new filling line will also be able to prepare source vessels containing Mo-99 generated from natural or enriched molybdenum-98 (Mo-98) targets, which have higher concentrations of Mo-98 and produce approximately three times more Mo-99 than natural targets. Installation is scheduled to begin in November 2106, with full operability targeted for the first half of 2017.
Mo-99 is the parent isotope of technetium-99m, the most widely used radioisotope in medical diagnostic imaging. Because of its unstable nature, Mo-99 does not occur naturally, and is traditionally produced using highly enriched uranium (HEU) in aging nuclear reactors, creating safety and national security concerns and the risk of product shortages. NorthStar is investing more than USD three million in the development of new processes for producing Mo-99 without the use of HEU.
It is striving to become the first producer of Mo-99 in the United States after more than 25 years, while facing competition from SHINE Medical Technologies (SHINE; Monona, WI, USA), which is also developing an alternative production method involving bombarding a low enriched uranium (LEU) uranyl sulfate solution with fast neutrons at the linear accelerator at Argonne National Laboratory (ANL; Lemont, IL, USA).
Related Links:
NorthStar Medical Radioisotopes
University of Missouri Research Reactor
Von Gahlen International
SHINE Medical Technologies
Argonne National Laboratory
The new high-capacity medical radioisotope filling line will be installed at the University of Missouri Research Reactor (MURR; Columbia, MO, USA) by Von Gahlen International (Zevenaar, The Netherlands). The system will include a high-capacity DPharm unit to fill source vessels quickly, along with companion nuclear radiation containment chambers. The vessels will then be shipped to customers for use with the RadioGenix isotope separation system.
In addition to significantly increasing dispensing capacity at MURR, the new filling line will also be able to prepare source vessels containing Mo-99 generated from natural or enriched molybdenum-98 (Mo-98) targets, which have higher concentrations of Mo-98 and produce approximately three times more Mo-99 than natural targets. Installation is scheduled to begin in November 2106, with full operability targeted for the first half of 2017.
Mo-99 is the parent isotope of technetium-99m, the most widely used radioisotope in medical diagnostic imaging. Because of its unstable nature, Mo-99 does not occur naturally, and is traditionally produced using highly enriched uranium (HEU) in aging nuclear reactors, creating safety and national security concerns and the risk of product shortages. NorthStar is investing more than USD three million in the development of new processes for producing Mo-99 without the use of HEU.
It is striving to become the first producer of Mo-99 in the United States after more than 25 years, while facing competition from SHINE Medical Technologies (SHINE; Monona, WI, USA), which is also developing an alternative production method involving bombarding a low enriched uranium (LEU) uranyl sulfate solution with fast neutrons at the linear accelerator at Argonne National Laboratory (ANL; Lemont, IL, USA).
Related Links:
NorthStar Medical Radioisotopes
University of Missouri Research Reactor
Von Gahlen International
SHINE Medical Technologies
Argonne National Laboratory
Latest Radiography News
- Novel Breast Imaging System Proves As Effective As Mammography
- AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
- AI Could Boost Clinical Adoption of Chest DDR
- 3D Mammography Almost Halves Breast Cancer Incidence between Two Screening Tests
- AI Model Predicts 5-Year Breast Cancer Risk from Mammograms
- Deep Learning Framework Detects Fractures in X-Ray Images With 99% Accuracy
- Direct AI-Based Medical X-Ray Imaging System a Paradigm-Shift from Conventional DR and CT
- Chest X-Ray AI Solution Automatically Identifies, Categorizes and Highlights Suspicious Areas
- AI Diagnoses Wrist Fractures As Well As Radiologists
- Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%
- 3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery
- Novel AI Technology to Revolutionize Cancer Detection in Dense Breasts
- AI Solution Provides Radiologists with 'Second Pair' Of Eyes to Detect Breast Cancers
- AI Helps General Radiologists Achieve Specialist-Level Performance in Interpreting Mammograms
- Novel Imaging Technique Could Transform Breast Cancer Detection
- Computer Program Combines AI and Heat-Imaging Technology for Early Breast Cancer Detection